Lipid and Foam Cell Accumulation as Novel Pathological Features of Benign Prostatic Hyperplasia
Authors:
Open Access
- 26 May 2026
- journal article
- Published by Wiley in The Prostate
- Vol. 86 (10) , 1157-1169
Abstract
Background: Benign prostatic hyperplasia (BPH) encompasses a heterogeneous set of pathological processes that instigate lower urinary tract symptoms (LUTS). Using a mouse model of steroid hormone imbalance–induced lower urinary tract dysfunction, we identified luminal lipid‐laden foamy macrophages, although their presence and contribution to human pathology have not yet been established. The objective of this study was to determine whether luminal macrophages are associated with human BPH and to assess how lipid accumulation relates to underlying pathological features and clinical parameters. Methods: Whole‐mount tissue sections from simple prostatectomy specimens and prostates from healthy donors were used to evaluate the association of luminal macrophages by immunohistochemistry and lipid content by Oil Red O staining. For a systematic assessment of inflammatory cells (CD45⁺ and CD68⁺), collagen content (Picrosirius Red), glandular proportion (H&E), and lipid accumulation, prostate tissues were obtained from patients undergoing holmium laser enucleation of the prostate (HoLEP). Clinical data, including IPSS and LURN symptom scores, were collected, and relevant clinical variables were extracted by chart review. Pathological subtypes were subsequently identified using unsupervised hierarchical clustering. Results: Lumens containing CD68⁺ macrophages were increased 6.2‐fold and 6.6‐fold in glandular nodules and internodular regions, respectively, compared with the transition zone of donors. Overall lipid content was also elevated by 2.8‐fold in glandular nodules relative to healthy transition zone tissue. In HoLEP specimens, lipid content showed positive correlations with glandular proportion, CD45⁺ and CD68⁺ cell abundance, prostate volume, and serum PSA, and negative correlations with collagen content and body mass index. Unsupervised hierarchical clustering of pathological features identified four distinct subtypes: a small, stromal‐fibrotic phenotype; a glandular‐enriched, low‐immune phenotype; a large‐prostate subtype characterized by high lipid content and inflammation; and a macrophage‐enriched phenotype. Notably, the small stromal‐fibrotic subtype was enriched for patients receiving 5α‐reductase inhibitor therapy. Conclusions: In summary, our findings identify luminal macrophages and lipid accumulation as previously underrecognized pathological features of BPH. Lipid accumulation is associated with prostatic inflammation and may represent a therapeutic target. Luminal macrophages may further contribute to disease progression, and comprehensive transcriptomic and proteomic characterization of these cells in human tissue will be essential to elucidate their pathological functions. Importantly, effective implementation of subtype‐informed BPH management will require improved biomarkers and imaging strategies to enable accurate disease stratification and personalized treatment selection.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK127150)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK139114)
- Eastern Virginia Medical School
This publication has 41 references indexed in Scilit:
- Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5‐alpha reductase inhibitor resistanceThe Prostate, 2024
- Histologic inflammation and collagen content are not positively correlated in human BPHThe Prostate, 2023
- Steroid hormone imbalance drives macrophage infiltration and Spp1/osteopontin+ foam cell differentiation in the prostateThe Journal of Pathology, 2023
- Promotion of epithelial hyperplasia by interleukin‐8—CXCR axis in human prostateThe Prostate, 2020
- Pathogenesis of Nonalcoholic Steatohepatitis: An OverviewHepatology Communications, 2020
- E‐cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayerThe Prostate, 2019
- Relation between histological prostatitis and lower urinary tract symptoms and erectile functionProstate International, 2017
- Prostatic Fibrosis is Associated with Lower Urinary Tract SymptomsJournal of Urology, 2012
- Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trialsUrology, 1996
- The Relative Proportion of Stromal and Epithelial Hyperplasia is Related to the Development of Symptomatic Benign Prostate HyperplasiaJournal of Urology, 1992